.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
McKesson
Medtronic
Fish and Richardson
Federal Trade Commission
AstraZeneca
Cerilliant
Colorcon
Julphar
Chubb

Generated: January 24, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: PCT/IB2008/053252

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-001Dec 21, 2015RXYesNo➤ Subscribe➤ SubscribeMETHOD OF TREATING PULMONARY ARTERIAL HYPERTENSION COMPRISING ADMINISTERING SELEXIPAG IN COMBINATION WITH THE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-002Dec 21, 2015RXYesNo➤ Subscribe➤ SubscribeMETHOD OF TREATING PULMONARY ARTERIAL HYPERTENSION COMPRISING ADMINISTERING SELEXIPAG IN COMBINATION WITH THE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-003Dec 21, 2015RXYesNo➤ Subscribe➤ SubscribeMETHOD OF TREATING PULMONARY ARTERIAL HYPERTENSION COMPRISING ADMINISTERING SELEXIPAG IN COMBINATION WITH THE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-004Dec 21, 2015RXYesNo➤ Subscribe➤ SubscribeMETHOD OF TREATING PULMONARY ARTERIAL HYPERTENSION COMPRISING ADMINISTERING SELEXIPAG IN COMBINATION WITH THE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-005Dec 21, 2015RXYesNo➤ Subscribe➤ SubscribeMETHOD OF TREATING PULMONARY ARTERIAL HYPERTENSION COMPRISING ADMINISTERING SELEXIPAG IN COMBINATION WITH THE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-006Dec 21, 2015RXYesNo➤ Subscribe➤ SubscribeMETHOD OF TREATING PULMONARY ARTERIAL HYPERTENSION COMPRISING ADMINISTERING SELEXIPAG IN COMBINATION WITH THE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-007Dec 21, 2015RXYesNo➤ Subscribe➤ SubscribeMETHOD OF TREATING PULMONARY ARTERIAL HYPERTENSION COMPRISING ADMINISTERING SELEXIPAG IN COMBINATION WITH THE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-008Dec 21, 2015RXYesYes➤ Subscribe➤ SubscribeMETHOD OF TREATING PULMONARY ARTERIAL HYPERTENSION COMPRISING ADMINISTERING SELEXIPAG IN COMBINATION WITH THE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist